Related Experiment Videos
Diabetes self-management education: miles to go
Helen Altman Klein1, Sarah M Jackson, Kenley Street
1Division of Research, MacroCognition LLC, P.O. Box 533, Yellow Springs, OH 45387, USA.
Nursing Research and Practice
|April 12, 2013
Summary
Diabetes Self-Management Education (DSME) modestly reduced A1c levels in type 2 diabetes patients. Nurse-led programs showed better results, but long-term maintenance and cognitive skills require further focus.
Area of Science:
- Endocrinology
- Public Health
- Behavioral Medicine
Background:
- Type 2 diabetes management requires effective patient education.
- Diabetes Self-Management Education (DSME) aims to improve glycemic control.
- Sustaining healthy blood glucose levels remains a challenge for many patients.
Purpose of the Study:
- To meta-analyze the effectiveness of DSME interventions on A1c levels in type 2 diabetes.
- To identify factors influencing the success of DSME programs.
- To explore strategies for improving long-term A1c maintenance.
Main Methods:
- Meta-analysis of 52 randomized controlled trials involving 9,631 participants.
- Inclusion of studies reporting post-intervention A1c levels.
- Comparison of DSME intervention groups with control groups.
Main Results:
- DSME interventions significantly reduced A1c levels compared to controls.
- A modest 7.23% shift towards healthier A1c status was observed.
- Nurse-delivered interventions were more effective than those by non-nursing staff.
- Few studies assessed long-term A1c maintenance, which is difficult to sustain.
Conclusions:
- DSME shows modest benefits for A1c reduction in type 2 diabetes.
- Nurse-led programs and enhanced cognitive skills may improve outcomes.
- Future DSME programs should incorporate comprehensive descriptions and cognitive self-monitoring skills for better long-term results.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...